This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Global Med Technologies(R) Reports Q4 And Year End Results

DENVER, March 9 /PRNewswire-FirstCall/ -- Global Med Technologies®, Inc. (OTC Bulletin Board: GLOB) ("Global Med" or the "Company"), an international e-Health, medical information technology company, today is reporting fourth quarter and year ended December 31, 2009 results.


    Global Med Technologies, Inc. (OTC Bulletin Board: GLOB.OB)
                          Selected Results
                   Three Months Ended December 31, 
                             In (000s) 
                    Except Per Share Information
                                      2009               2008
                                      ----               ----
    Revenues                         $8,113             $6,991
    Depreciation and
     amortization                       375                332
    Loss from operations (1)            (97)              (664)
    Other income (expense)             (166)              (170)
    Pre-tax loss                       (263)              (834)
    Income taxes benefit                 44                131
    Net loss (1)                      $(219)             $(703)
    Basic and diluted net loss
     per share (1)
    Basic                            $(0.01)            $(0.02)
    Diluted                          $(0.01)            $(0.02)
    Weighted average number of
     common shares outstanding
    Basic                            36,381             34,019
    Diluted                          36,381             34,019
    EBITDA (1)                         $278              $(332)
    Global Med Technologies, Inc. (OTC Bulletin Board: GLOB.OB)
                           Selected Results
                        Year Ended December 31, 
                  In (000s) Except Per Share Information
                                     2009               2008
                                     ----               ----
    Revenues                        $31,788            $23,369
    Depreciation and
     amortization                     1,418                794
    Income from operations (1) (2)    2,705                176
    Other income (expense)             (708)              (296)
    Pre-tax income (loss)             1,997               (120)
    Income taxes (2)                   (519)              (299)
    Net income (loss)                $1,478              $(419)
    Basic and diluted net
     income (loss) per share (1)
    Basic                             $0.04             $(0.01)
    Diluted                           $0.03             $(0.01)
    Weighted average number of
     common shares outstanding
    Basic                            35,177             29,914
    Diluted                          44,760             29,914
    EBITDA (1) (2)                   $4,123               $970

(1) Includes $450 thousand in costs related to the potential acquisition of the Company by Haemonetics Corporation ("Haemonetics"). These costs were expensed in the fourth quarter of 2009 and represent estimates.

(2) On September 23, 2002, the Company and, Inc. (" PeopleMed") filed a complaint against Donnie L. Jackson, Jr. (" Jackson") in a lawsuit entitled Global Med Technologies, Inc. v. Donnie L. Jackson, Jr. , et al, El Dorado Superior Court Case No. PC 20020576 (the "Lawsuit").  During 2005, the Company set up a legal accrual in the amount of $1.004 million and expensed the same amount. In 2005, the Company also deposited $1.004 million into escrow related to the Lawsuit. During 2007, the Company was returned the $1.004 million deposit. The Lawsuit was settled in 2009 and claims were released. No amount was paid by Global Med to Jackson or Mediware Information Systems, Inc. ("Mediware") and no amount was paid by Jackson or Mediware to Global Med in connection with such settlement. Jackson made a representation as part of the settlement that he does not have possession of any trade secret or proprietary material of the Company described in its complaint for damages. As a result of the above, the Company reversed the $1.004 million legal accrual and the related expense during the year ended December 31, 2009. This represents a reversal of a non-cash, non-recurring expense as the funds were returned in 2007.


(in thousands)

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
GLOB $21.07 13.89%
AAPL $123.25 -0.80%
FB $83.30 0.35%
GOOG $548.34 -1.23%
TSLA $185.00 -2.84%


DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs